XML 40 R28.htm IDEA: XBRL DOCUMENT v3.21.1
CHANGE IN CONTROL AND REVERSE RECAPITALIZATION TRANSACTIONS (Details) - USD ($)
Jan. 31, 2021
Oct. 31, 2020
Jul. 31, 2020
Apr. 13, 2020
Preferred stock $ 202   $ 202  
Common stock 12,127   9,669  
Additional paid-in capital 3,357,356   1,456,644  
Adjustment to stockholders' equity (deficiency) 819,826 $ 147,250 (150,341)  
Series B Preferred Stock        
Preferred stock 72   72  
Adjustment to stockholders' equity (deficiency) $ 72 $ 72 $ 72  
Bio-Matrix Scientific Group, Inc        
Cash       $ 572
Investment securities       8,797
Total current assets       9,369
Preferred stock       202
Common stock       781
Additional paid-in capital       8,314
Adjustment to stockholders' equity (deficiency)       9,369
Bio-Matrix Scientific Group, Inc | Series B Preferred Stock        
Preferred stock       $ 72